Prognostic factors in cancer of unknown primary site

被引:15
作者
Jose Fernandez-Cotarelo, Maria [1 ]
Manuel Guerra-Vales, Juan [2 ]
Colina, Francisco [3 ]
de la Cruz, Javier [4 ]
机构
[1] Hosp Mostoles, Dept Internal Med, Madrid 28935, Spain
[2] Univ Hosp 12 Octubre, CIBERESP, Dept Internal Med, Madrid, Spain
[3] Univ Hosp 12 Octubre, CIBERESP, Dept Pathol, Madrid, Spain
[4] Univ Hosp 12 Octubre, CIBERESP, Clin Epidemiol Unit, Madrid, Spain
来源
TUMORI JOURNAL | 2010年 / 96卷 / 01期
关键词
tumor metastasis; unknown primary tumors; survival; prognosis; SERUM-ALBUMIN LEVELS; PRIMARY-CARCINOMA; LIVER METASTASIS; PRIMARY ORIGIN; PRIMARY TUMORS; SURVIVAL; MANAGEMENT; MARKERS; MODEL; EXPERIENCE;
D O I
10.1177/030089161009600118
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aims and background. Patients with cancer of an unknown primary site (CUP) usually have a poor outcome. The identification of prognostic factors that affect survival can help clinicians find a better approach to such cases in terms of diagnostic and therapeutic management. Methods. We conducted a retrospective study including the cases of CUP recorded at the University Hospital 12 de Octubre Tumor Registry between 1999 and 2003. Results. CUP was diagnosed in 265 patients during the analyzed period. One hundred and seventy-one were men (64.5%) and the mean age of the patients was 66.9 years (range 32-98 years). The median survival was 2.5 months, and the survival rate was 35.1% 6 months from diagnosis (95% CI: 28.9-41.3) and 24.5% 1 year from diagnosis (95% CI:.18.7-30.3). Univariate analysis revealed as significant predictive variables of a better outcome age under 70 years; involvement of a single organ; normal serum levels of alkaline phosphatase and albumin; normal erythrocyte sedimentation rate; normal levels of the serum tumor markers CEA, CA 19.9 and CA 15.3; squamous carcinoma histology; clinical presentation as lymph node enlargement; and the administration of treatment. Multivariate analysis showed that albumin and alkaline phosphatase levels, squamous carcinoma histology, age and treatment were the most important prognostic factors. Other variables analyzed (liver, bone or lung involvement, lactate dehydrogenase levels, gender) did not affect survival. Conclusions. CUP has a poor prognosis. Some prognostic factors that affect survival in these patients, however, may be identified. Free full text available at www.turnorionline.it
引用
收藏
页码:111 / 116
页数:6
相关论文
共 37 条
[1]   UNKNOWN PRIMARY-CARCINOMA - NATURAL-HISTORY AND PROGNOSTIC FACTORS IN 657 CONSECUTIVE PATIENTS [J].
ABBRUZZESE, JL ;
ABBRUZZESE, MC ;
HESS, KR ;
RABER, MN ;
LENZI, R ;
FROST, P .
JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (06) :1272-1280
[2]  
Al-Brahim Nabeel, 2005, Ann Diagn Pathol, V9, P77, DOI 10.1016/j.anndiagpath.2004.12.003
[3]  
ALTMAN E, 1986, CANCER-AM CANCER SOC, V57, P120, DOI 10.1002/1097-0142(19860101)57:1<120::AID-CNCR2820570124>3.0.CO
[4]  
2-M
[5]  
Antuna Egocheaga A, 2002, Anales de Medicina Interna, V19, P405
[6]   Concurrent chemoradiotherapy for N2 or N3 squamous cell carcinoma of the head and neck from an occult primary [J].
Argiris, A ;
Smith, SM ;
Stenson, K ;
Mittal, BB ;
Pelzer, HJ ;
Kies, MS ;
Haraf, DJ ;
Vokes, EE .
ANNALS OF ONCOLOGY, 2003, 14 (08) :1306-1311
[7]   Prognostic value of monitoring tumour markers CA 15-3 and CEA during fulvestrant treatment [J].
Bartsch, R ;
Wenzel, C ;
Pluschnig, U ;
Hussian, D ;
Sevelda, U ;
Altorjai, G ;
Locker, GJ ;
Mader, R ;
Zielinski, CC ;
Steger, GG .
BMC CANCER, 2006, 6 (1)
[8]   Cancer of unknown primary:: clinicopathologic correlations [J].
Blaszyk, H ;
Hartmann, A ;
Björnsson, J .
APMIS, 2003, 111 (12) :1089-1094
[9]   Summary of the Standards, Options and Recommendations for the management of patients with carcinoma of unknown primary site (2002) [J].
Bugat, R ;
Bataillard, A ;
Lesimple, T ;
Voigt, JJ ;
Culine, S ;
Lortholary, A ;
Merrouche, Y ;
Ganem, G ;
Kaminsky, MC ;
Negrier, S ;
Perol, M ;
Laforêt, C ;
Bedossa, P ;
Bertrand, G ;
Coindre, JM ;
Fizazi, K .
BRITISH JOURNAL OF CANCER, 2003, 89 (Suppl 1) :S59-S66
[10]   Development and validation of a prognostic model to predict the length of survival in patients with carcinomas of an unknown primary site [J].
Culine, S ;
Kramar, A ;
Saghatchian, M ;
Bugat, R ;
Lesimple, T ;
Lortholary, A ;
Merrouche, Y ;
Laplanche, A ;
Fizazi, K .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (24) :4679-4683